XENOGENEIC ENDOTHELIAL CELLS ACTIVATE HUMAN PROTHROMBIN1,2Jonathan B. Siegel, Simon C. Robson, Miguel P. Soares et al.|Transplantation|1997Cited by 115
EFFECT OF REPETITIVE HIGH-DOSE TREATMENT WITH SOLUBLE COMPLEMENT RECEPTOR TYPE 1 AND COBRA VENOM FACTOR ON DISCORDANT XENOGRAFT SURVIVAL1,2Daniel Candinas, Fritz H. Bach, Beth‐Ann Lesnikoski et al.|Transplantation|1996Cited by 59